- Home
- SCPH vs GF Comparison
SCPH vs GF Comparison
Compare SCPH & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- GF
- Stock Information
- Founded
- SCPH 2013
- GF 1990
- Country
- SCPH United States
- GF Germany
- Employees
- SCPH N/A
- GF N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- GF Investment Managers
- Sector
- SCPH Health Care
- GF Finance
- Exchange
- SCPH Nasdaq
- GF Nasdaq
- Market Cap
- SCPH 173.6M
- GF 155.4M
- IPO Year
- SCPH 2017
- GF N/A
- Fundamental
- Price
- SCPH $3.64
- GF $11.59
- Analyst Decision
- SCPH Strong Buy
- GF
- Analyst Count
- SCPH 3
- GF 0
- Target Price
- SCPH $14.00
- GF N/A
- AVG Volume (30 Days)
- SCPH 423.8K
- GF 28.1K
- Earning Date
- SCPH 05-14-2025
- GF 01-01-0001
- Dividend Yield
- SCPH N/A
- GF 0.82%
- EPS Growth
- SCPH N/A
- GF N/A
- EPS
- SCPH N/A
- GF N/A
- Revenue
- SCPH $41,982,000.00
- GF N/A
- Revenue This Year
- SCPH $109.32
- GF N/A
- Revenue Next Year
- SCPH $76.95
- GF N/A
- P/E Ratio
- SCPH N/A
- GF N/A
- Revenue Growth
- SCPH 138.10
- GF N/A
- 52 Week Low
- SCPH $1.94
- GF $7.38
- 52 Week High
- SCPH $5.65
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- SCPH 66.63
- GF 75.39
- Support Level
- SCPH $3.23
- GF $11.34
- Resistance Level
- SCPH $3.74
- GF $11.72
- Average True Range (ATR)
- SCPH 0.31
- GF 0.16
- MACD
- SCPH 0.08
- GF 0.02
- Stochastic Oscillator
- SCPH 93.81
- GF 85.56
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.